NCT03147053View on ClinicalTrials.gov

Efficacy and Safety of Jiedu Tongluo Granules for Post-stroke Depression

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

April 27, 2017

Primary Completion Date

July 7, 2017

Study Completion Date

January 24, 2018

Conditions
Post-stroke Depression
Interventions
DRUG

Jiedu Tongluo granules

Patients in this group were administered the Jiedu Tongluo granules, 3.9mg/bag, 2 times/day for 8 weeks.

DRUG

Placebo

Patients in this group were administered the placebo, 3.9mg/bag, 2 times/day for 8 weeks.

Trial Locations (1)

Unknown

Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing

All Listed Sponsors
lead

Xiyuan Hospital of China Academy of Chinese Medical Sciences

OTHER

NCT03147053 - Efficacy and Safety of Jiedu Tongluo Granules for Post-stroke Depression | Biotech Hunter | Biotech Hunter